Insider Trading & Ownership - Alles Mark J

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Alles Mark J
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-10-31
Purchase
2022-11-02
6:42 pm
BIOMARIN PHARMACEUTICAL INCBMRNAlles Mark J
Director
3,625$86.75$314,46910,905
(Direct)
View
2021-06-21
Purchase
2021-06-21
9:14 pm
Turning Point Therapeutics Inc.TPTXAlles Mark J
Director
2,000$81.34$162,6802,000
(Direct)
View
2020-05-13
Purchase
2020-05-13
5:05 pm
Syros Pharmaceuticals Inc.SYRSAlles Mark J
Director
10,000$8.859$88,59010,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-09-16
Exercise
2023-09-19
4:47 pm
N/A
N/A
Syros Pharmaceuticals Inc.SYRSAlles Mark J
Director
2,666$09,000
(Direct)
View
2023-06-01
Option Award
2023-06-02
4:22 pm
N/A
2033-05-31
Syros Pharmaceuticals Inc.SYRSAlles Mark J
Director
10,000$010,000
(Direct)
View
2023-05-23
Option Award
2023-05-24
6:23 pm
N/A
N/A
BIOMARIN PHARMACEUTICAL INCBMRNAlles Mark J
Director
4,190$015,095
(Direct)
View
2022-09-16
Option Award
2022-09-19
5:08 pm
N/A
2032-09-15
Syros Pharmaceuticals Inc.SYRSAlles Mark J
Director
20,000$020,000
(Direct)
View
2022-08-17
Disposition
2022-08-17
4:32 pm
N/A
2031-05-23
Turning Point Therapeutics Inc.TPTXAlles Mark J
Director
17,209$00
(Direct)
View
2022-08-17
Disposition
2022-08-17
4:32 pm
N/A
N/A
Turning Point Therapeutics Inc.TPTXAlles Mark J
Director
2,000$760
(Direct)
View
2022-06-01
Option Award
2022-06-02
7:06 pm
N/A
2032-05-31
Syros Pharmaceuticals Inc.SYRSAlles Mark J
Director
17,500$017,500
(Direct)
View
2022-05-24
Option Award
2022-05-26
8:12 pm
N/A
N/A
BIOMARIN PHARMACEUTICAL INCBMRNAlles Mark J
Director
4,980$07,280
(Direct)
View
2022-01-03
Option Award
2022-01-05
6:09 pm
N/A
N/A
BIOMARIN PHARMACEUTICAL INCBMRNAlles Mark J
Director
2,300$02,300
(Direct)
View
2021-06-08
Option Award
2021-06-10
5:24 pm
N/A
2031-06-07
Syros Pharmaceuticals Inc.SYRSAlles Mark J
Director
17,500$017,500
(Direct)
View
2021-06-02
Option Award
2021-06-04
5:34 pm
N/A
2031-06-01
Turning Point Therapeutics Inc.TPTXAlles Mark J
Director
209$0209
(Direct)
View
2021-05-24
Option Award
2021-05-26
4:50 pm
N/A
2031-05-23
Turning Point Therapeutics Inc.TPTXAlles Mark J
Director
17,000$017,000
(Direct)
View
2020-06-11
Option Award
2020-06-11
4:51 pm
N/A
2030-06-10
Syros Pharmaceuticals Inc.SYRSAlles Mark J
Director
17,500$017,500
(Direct)
View
2019-12-19
Option Award
2019-12-20
08:14 am
N/A
2029-12-18
Syros Pharmaceuticals Inc.SYRSAlles Mark J
Director
35,000$035,000
(Direct)
View
2019-11-20
Option Award
2019-11-22
07:31 am
N/A
N/A
CELGENE CORPCELGAlles Mark J
CEO, CHAIRMAN OF BOARD
145,229$00
(Direct)
View
2019-11-20
Disposition
2019-11-22
07:31 am
N/A
2022-03-01
CELGENE CORPCELGAlles Mark J
CEO, CHAIRMAN OF BOARD
679,555$00
(Direct)
View
2019-11-20
Disposition
2019-11-22
07:31 am
N/A
2026-10-31
CELGENE CORPCELGAlles Mark J
CEO, CHAIRMAN OF BOARD
554,328$00
(Direct)
View